Using this selection, we employed the previously reported magnetic nanoparticles (NC@silica-SA) and the FETCH separation system to evaluate the effect of combining anti-EpCAM and anti-ofCS (rVAR2) to enhance the recovery efficiency of NSCLC cell lines from blood [12]. The gene discussed is EPCAM; the disease is non-small cell lung carcinoma.